Global Anti-Depression Devices & Therapy Market

Global Anti-Depression Devices & Therapy Market Size, Trends & Analysis - Forecast to 2026 By Product (Light Therapy, Stimulation Therapies, Electro Stimulator Devices, Helmet Therapy), By Type (Psychotic Depression, Persistent Depressive Disorder, Postpartum Depression, Major Depression, Seasonal Affective Disorder), By End-Use (Hospitals, Homecare Setting, Long Term Centers, Out Patient Settings), By Region (North America, Asia Pacific, Europe, Latin America, Middle East & Africa); End-User Landscape, Company Market Share Analysis, and Competitor Analysis

Category Healthcare
Format
  • ms word
  • ms excel
  • ms ppt
  • pdf
This report was recently updated on May 21 2023 with the latest and most recent market numbers

Anti-Depression Devices & Therapy Market Insights

Increasing stress and anxiety among the young and geriatric population owing to the changing lifestyle has resulted in depression in a large number of the population. As per World Health Organization, over 260 million people were diagnosed with depression in 2020 which is a major cause leading to suicide, disability, and crime. Thus, to combat the increased depression ratio, the organization is helping countries to launch various services to help people with mental and neurological disorders.

Rising depression cases have forced the healthcare industry to come up with a more reliable and long-term solution. The antidepressants are not enough to resolve some neurological disorders. Therefore, the emergence of more technologically advanced therapies will help the healthcare industry to achieve its goal.

The emergence of virtual reality and artificial intelligence in various rehabilitation therapies proved to be more effective than some medications. Thus, the introduction of Anti-Depression Devices & Therapy to heal patients will be a more productive and consistent method. Various technically advanced products are being commercialized to treat patients in hospitals as well as on personal care levels.

Various products are being commercialized such as stimulators, wearable gadgets, and electroconvulsive therapy to treat various disorders depending on the neurological disorder level. Other causes such as mental illness due to accidents, bad incidences, death of a loved one, and other chronic illness will instigate the Anti-Depression Devices & Therapy adoption.

Change in eating habits and lifestyle has led to sleep disorder, anxiety, stress, and insomnia among the young population which is indicated to become more chronic with aging. Therefore, the introduction of self mental care products such as wearable neurological headsets may reduce the negative impact on the people wearing them.  

Studies have shown that most women are left undiagnosed & untreated from mental disorders caused due to puberty, pregnancy, menstruation, miscarriage, menopause,and other hormonal changes. This happens due to negligence which makes them more vulnerable to prolonged neurological illness. Therefore, the adoption and implementation of Anti-Depression Devices & Therapy is vital to protect the mental health of people across all ages and groups.

global anti-depression devices & therapy market

Anti-Depression Devices & Therapy Market: By Product

Light therapy, stimulation therapies, electro stimulator devices, and helmet therapy are major products identified in the Anti-Depression Devices & Therapy market. Electro stimulators are among the most commonly used products in the industry. High success rate and absence of side effects have influenced growth in this segment.

Light therapy is an effective method to cure mental illness in less time. Also, this therapy helps in lightening mood, uplifting mood swings, and ease the symptoms. In the case of seasonal affective disorder or non-seasonal depression, it will not be as effective as other products.

Helmets are expected to gain the highest growth during the forecast period. Improved symptoms, fast recovery, positive physiological impact due to impactful brain stimulation will support the product penetration.

Anti-Depression Devices & Therapy Market: By Type

Psychotic depression, postpartum depression, major depression,persistent depressive disorder, and seasonal affective disorder are key disorder types included in the industry. Major depression will be the key contributor in the industry owing to the increasingly stressful lifestyle and anxiety among a large population. Various medications are commercialized to treat the disorder. However, the most effective method is through Anti-Depression Devices & Therapy.

As per the studies, postpartum is among the negligence disorder types in the medical industry. Mixing up the symptoms with hormonal changes and physical fatigue may result in undiagnosed postpartum depression. This segment is gaining popularity and is projected toforesee the highest growthowing to the growing importance of women's mental health by the welfare organizations.

Anti-Depression Devices & Therapy Market: By End-Use

Hospitals, homecare settings, and longer-term centers are major contributing end-users in the Anti-Depression Devices & Therapy market. Hospitals are projected to gain maximum share during the forecast period. The introduction of various mental health programs by the government in the hospitals will drive the product demand in this segment.

Homecare settings are gaining popularity since the commercialization of personalized wearable gadgets to overcome neurological disorders. Various people groups are adopting these gadgets in the form of headsets to treat themselves from insomnia, anxiety, and negative thoughts.

asia pacific anti-depression devices & therapy market

Anti-Depression Devices & Therapy Market: By Region

The North America Anti-Depression Devices & Therapy market will dominate the regional share. Increasing mental disorder incidences among the young and geriatric population owing to hectic & competitive lifestyles will support the regional industry growth. The introduction of various healthcare welfare programs to improve mental health and suicide prevention will result in high penetration.

Asia Pacific is expected to be the highly lucrative region with the highest CAGR over the forecast period. Healthcare industry expansion and government agenda to fight against suicide and crime caused due to depression will drive the regional industry growth. China, South Korea, Japan, and Singapore are the major contributing countries.

Anti-Depression Devices & Therapy Market Share and Competitor Analysis

Fisher Wallace, Boston Scientific Corporation, Neuro-Fitness LLC, Brainsway Ltd, Electromedical Products International, Inc., Sorterix Medical Inc, MagVenture A/S, Flow Neuroscience, Alpha-Stim, Pear Therapeutics, Neuronetics, CervelNeurotech, Magstim, Limbix, NeuroSigma, Vagus nerve stimulation, Koa Health, Sentio, and Cervella are among major participants in the industry.

Please note: This is not an exhaustive list of companies profiled in the report.

The industry share is competitive and fragmented owing to the presence of a large number of multinational companies with technologically advanced products. Product improvement and technology advancement will be the major strategies.

Chapter 1   Methodology

1.1    Market scope & definitions

1.2    Estimates & forecast calculation

1.3    Historical data overview and validation

1.4    Data sources

1.4.1    Secondary

1.4.2    Primary

Chapter 2   Report Outlook

2.1    Anti-depression devices & therapy industry overview, 2016-2026

2.1.1    Industry overview

2.1.2    Product overview

2.1.3    Type overview

2.1.4    End-Use overview

2.1.5    Regional overview

Chapter 3   Anti-Depression Devices & Therapy Market Trends

3.1    Market segmentation

3.2    Industry background, 2016-2026

3.3    Market key trends

3.3.1    Positive trends

3.3.2    Industry challenges

3.4    Prospective growth scenario

3.4.1    Application growth scenario

3.4.2    End-Use growth scenario

3.5    COVID-19 influence over industry growth

3.6    Porter’s analysis

3.7    PESTEL analysis

3.8    Value chain & supply chain analysis

3.9    Regulatory framework

3.9.1    North America

3.9.2    Europe

3.9.3    APAC

3.9.4    LATAM

3.9.5    MEA

3.10    Technology overview

3.11    Market share analysis, 2020

3.11.1    Company positioning overview, 2020

Chapter 4   Anti-Depression Devices & Therapy Market, By Product

4.1    Product Outlook

4.2    Light Therapy

4.2.1    Market size, by region, 2016-2026 (USD Million)

4.3    Stimulation Therapies

4.3.1    Market size, by region, 2016-2026 (USD Million)

4.4    Electro Stimulator Devices

4.4.1    Market size, by region, 2016-2026 (USD Million)

4.5    Helmet Therapy

4.5.1    Market size, by region, 2016-2026 (USD Million)

4.6    Others

4.6.1    Market size, by region, 2016-2026 (USD Million)

Chapter 5   Anti-Depression Devices & Therapy Market, By Type

5.1    Type Outlook

5.2    Psychotic Depression

5.2.1    Market size, by region, 2016-2026 (USD Million)

5.3    Persistent Depressive Disorder

5.3.1    Market size, by region, 2016-2026 (USD Million)

5.4    Postpartum Depression

5.4.1    Market size, by region, 2016-2026 (USD Million)

5.5    Major Depression

5.5.1    Market size, by region, 2016-2026 (USD Million)

5.6    Seasonal Affective Disorder

5.6.1    Market size, by region, 2016-2026 (USD Million)

5.7    Others

5.7.1    Market size, by region, 2016-2026 (USD Million)

Chapter 6   Anti-Depression Devices & Therapy Market, By End-Use

6.1    End-Use Outlook

6.2    Hospitals

6.2.1    Market size, by region, 2016-2026 (USD Million)

6.3    Homecare Setting

6.3.1    Market size, by region, 2016-2026 (USD Million)

6.4    Long Term Centers

6.4.1    Market size, by region, 2016-2026 (USD Million)

6.5    Out Patient Settings

6.5.1    Market size, by region, 2016-2026 (USD Million)

Chapter 7   Anti-Depression Devices & Therapy Market, By Region

7.1    Regional outlook

7.2    North America

7.2.1    Market size, by country 2016-2026 (USD Million)

7.2.2    Market size, by product, 2016-2026 (USD Million)

7.2.3    Market size, by type, 2016-2026 (USD Million)

7.2.4    Market size, by end-use, 2016-2026 (USD Million)

7.2.5    U.S.

7.2.5.1    Market size, by product, 2016-2026 (USD Million)

7.2.5.2    Market size, by type, 2016-2026 (USD Million)

7.2.5.3    Market size, by end-use, 2016-2026 (USD Million)

7.2.6    Canada

7.2.6.1    Market size, by product, 2016-2026 (USD Million)

7.2.6.2    Market size, by type, 2016-2026 (USD Million)

7.2.6.3    Market size, by end-use, 2016-2026 (USD Million)

7.3    Europe

7.3.1    Market size, by country 2016-2026 (USD Million)

7.3.2    Market size, by product, 2016-2026 (USD Million)

7.3.3    Market size, by type, 2016-2026 (USD Million)

7.3.4    Market size, by end-use, 2016-2026 (USD Million)

7.3.5    Germany

7.2.5.1    Market size, by product, 2016-2026 (USD Million)

7.2.5.2    Market size, by type, 2016-2026 (USD Million)

7.2.5.3    Market size, by end-use, 2016-2026 (USD Million)

7.3.6    UK

7.3.6.1    Market size, by product, 2016-2026 (USD Million)

7.3.6.2    Market size, by type, 2016-2026 (USD Million)

7.3.6.3    Market size, by end-use, 2016-2026 (USD Million)

7.3.7    France

7.3.7.1    Market size, by product, 2016-2026 (USD Million)

7.3.7.2    Market size, by type, 2016-2026 (USD Million)

7.3.7.3    Market size, by end-use, 2016-2026 (USD Million)

7.3.8    Italy

7.3.8.1    Market size, by product, 2016-2026 (USD Million)

7.3.8.2    Market size, by type, 2016-2026 (USD Million)

7.3.8.3    Market size, by end-use, 2016-2026 (USD Million)

7.3.9    Spain

7.3.9.1    Market size, by product, 2016-2026 (USD Million)

7.3.9.2    Market size, by type, 2016-2026 (USD Million)

7.3.9.3    Market size, by end-use, 2016-2026 (USD Million)

7.3.10    Russia

7.3.10.1    Market size, by product, 2016-2026 (USD Million)

7.3.10.2    Market size, by type, 2016-2026 (USD Million)

7.3.10.3    Market size, by end-use, 2016-2026 (USD Million)

7.4    Asia Pacific

7.4.1    Market size, by country 2016-2026 (USD Million)

7.4.2    Market size, by product, 2016-2026 (USD Million)

7.4.3    Market size, by type, 2016-2026 (USD Million)

7.4.4    Market size, by end-use, 2016-2026 (USD Million)

7.4.5    China

7.4.5.1    Market size, by product, 2016-2026 (USD Million)

7.4.5.2    Market size, by type, 2016-2026 (USD Million)

7.4.5.3    Market size, by end-use, 2016-2026 (USD Million)

7.4.6    India

7.4.6.1    Market size, by product, 2016-2026 (USD Million)

7.4.6.2    Market size, by type, 2016-2026 (USD Million)

7.4.6.3    Market size, by end-use, 2016-2026 (USD Million)

7.4.7    Japan

7.4.7.1    Market size, by product, 2016-2026 (USD Million)

7.4.7.2    Market size, by type, 2016-2026 (USD Million)

7.4.7.3    Market size, by end-use, 2016-2026 (USD Million)

7.4.8    Australia

7.4.8.1    Market size, by product, 2016-2026 (USD Million)

7.4.8.2    Market size, by type, 2016-2026 (USD Million)

7.4.8.3    Market size, by end-use, 2016-2026 (USD Million)

7.4.9    South Korea

7.4.9.1    Market size, by product, 2016-2026 (USD Million)

7.4.9.2    Market size, by type, 2016-2026 (USD Million)

7.4.9.3    Market size, by end-use, 2016-2026 (USD Million)

7.5    Latin America

7.5.1    Market size, by country 2016-2026 (USD Million)

7.5.2    Market size, by product, 2016-2026 (USD Million)

7.5.3    Market size, by type, 2016-2026 (USD Million)

7.5.4    Market size, by end-use, 2016-2026 (USD Million)

7.5.5    Brazil

7.5.5.1    Market size, by product, 2016-2026 (USD Million)

7.5.5.2    Market size, by type, 2016-2026 (USD Million)

7.5.5.3    Market size, by end-use, 2016-2026 (USD Million)

7.5.6    Mexico

7.5.6.1    Market size, by product, 2016-2026 (USD Million)

7.5.6.2    Market size, by type, 2016-2026 (USD Million)

7.5.6.3    Market size, by end-use, 2016-2026 (USD Million)

7.5.7    Argentina

7.5.7.1    Market size, by product, 2016-2026 (USD Million)

7.5.7.2    Market size, by type, 2016-2026 (USD Million)

7.5.7.3    Market size, by end-use, 2016-2026 (USD Million)

7.6    MEA

7.6.1    Market size, by country 2016-2026 (USD Million)

7.6.2    Market size, by product, 2016-2026 (USD Million)

7.6.3    Market size, by type, 2016-2026 (USD Million)

7.6.4    Market size, by end-use, 2016-2026 (USD Million)

7.6.5    Saudi Arabia

7.6.5.1    Market size, by product, 2016-2026 (USD Million)

7.6.5.2    Market size, by type, 2016-2026 (USD Million)

7.6.5.3    Market size, by end-use, 2016-2026 (USD Million)

7.6.6    UAE

7.6.6.1    Market size, by product, 2016-2026 (USD Million)

7.6.6.2    Market size, by type, 2016-2026 (USD Million)

7.6.6.3    Market size, by end-use, 2016-2026 (USD Million)

7.6.7    South Africa

7.6.7.1    Market size, by product, 2016-2026 (USD Million)

7.6.7.2    Market size, by type, 2016-2026 (USD Million)

7.6.7.3    Market size, by end-use, 2016-2026 (USD Million)

Chapter 8   Company Landscape

8.1    Competitive analysis, 2020

8.2    Fisher Wallace

8.2.1    Company overview

8.2.2    Financial analysis

8.2.3    Strategic positioning

8.2.4    Info graphic analysis

8.3    Boston Scientific Corporation

8.3.1    Company overview

8.3.2    Financial analysis

8.3.3    Strategic positioning

8.3.4    Info graphic analysis

8.4    Neuro-Fitness LLC

8.4.1    Company overview

8.4.2    Financial analysis

8.4.3    Strategic positioning

8.4.4    Info graphic analysis

8.5    Brainsway Ltd

8.5.1    Company overview

8.5.2    Financial analysis

8.5.3    Strategic positioning

8.5.4    Info graphic analysis

8.6    Electromedical Products International, Inc.

8.6.1    Company overview

8.6.2    Financial analysis

8.6.3    Strategic positioning

8.6.4    Info graphic analysis

8.7    MagVenture A/S

8.7.1    Company overview

8.7.2    Financial analysis

8.7.3    Strategic positioning

8.7.4    Info graphic analysis

8.8    Flow Neuroscience

8.8.1    Company overview

8.8.2    Financial analysis

8.8.3    Strategic positioning

8.8.4    Info graphic analysis

8.9    Alpha-Stim

8.9.1    Company overview

8.9.2    Financial analysis

8.9.3    Strategic positioning

8.9.4    Info graphic analysis

8.10    Pear Therapeutics

8.10.1    Company overview

8.10.2    Financial analysis

8.10.3    Strategic positioning

8.10.4    Info graphic analysis

8.11    Neuronetics

8.11.1    Company overview

8.11.2    Financial analysis

8.11.3    Strategic positioning

8.11.4    Info graphic analysis

8.12    Cervel Neurotech

8.12.1    Company overview

8.12.2    Financial analysis

8.12.3    Strategic positioning

8.12.4    Info graphic analysis

8.13    Brainsway

8.13.1    Company overview

8.13.2    Financial analysis

8.13.3    Strategic positioning

8.13.4    Info graphic analysis

8.14    Henan Yuntian Crane Co.,Ltd

8.14.1    Company overview

8.14.2    Financial analysis

8.14.3    Strategic positioning

8.14.4    Info graphic analysis

8.15    Magstim

8.15.1    Company overview

8.15.2    Financial analysis

8.15.3    Strategic positioning

8.15.4    Info graphic analysis

8.16    Limbix

8.16.1    Company overview

8.16.2    Financial analysis

8.16.3    Strategic positioning

8.16.4    Info graphic analysis

8.17    NeuroSigma

8.17.1    Company overview

8.17.2    Financial analysis

8.17.3    Strategic positioning

8.17.4    Info graphic analysis

8.18    Sentio

8.18.1    Company overview

8.18.2    Financial analysis

8.18.3    Strategic positioning

8.18.4    Info graphic analysis

8.19    Cervella

8.19.1    Company overview

8.19.2    Financial analysis

8.19.3    Strategic positioning

8.19.4    Info graphic analysis

8.20    Sorterix Medical Inc

8.20.1    Company overview

8.20.2    Financial analysis

8.20.3    Strategic positioning

8.20.4    Info graphic analysis

8.21    Vagus nerve stimulation

8.21.1    Company overview

8.21.2    Financial analysis

8.21.3    Strategic positioning

8.21.4    Info graphic analysis

8.22    Koa Health

8.22.1    Company overview

8.22.2    Financial analysis

8.22.3    Strategic positioning

8.22.4    Info graphic analysis   

The Global Anti-Depression Devices & Therapy Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Anti-Depression Devices & Therapy Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy

Tailor made solutions just for you

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

OUR CLIENTS

  • Client of Global Market Estimates - Fedex
  • Client of Global Market Estimates - Samsung
  • Client of Global Market Estimates - Siemens
  • Client of Global Market Estimates - Lonza
  • Client of Global Market Estimates - DuPont
  • Client of Global Market Estimates - Medtronic
  • Client of Global Market Estimates - Toray
  • Client of Global Market Estimates - Signify
  • Client of Global Market Estimates - Teledyne
  • Client of Global Market Estimates - Trelleborg
  • Client of Global Market Estimates - Kikkoman Biochemifa
  • Client of Global Market Estimates - Leoni
  • Client of Global Market Estimates - Molnlycke
  • Client of Global Market Estimates - Spirent
  • Client of Global Market Estimates - Tokyo Electron Limited
  • Client of Global Market Estimates - Aranca
  • Client of Global Market Estimates - Asahi Kasei
  • Client of Global Market Estimates - Chimai
  • Client of Global Market Estimates - Grapsud
  • Client of Global Market Estimates - Horiba
  • Client of Global Market Estimates - Indorama
  • Client of Global Market Estimates - L&T
  • Client of Global Market Estimates - Integralife
  • Client of Global Market Estimates - Synamedia
  • Client of Global Market Estimates - Sorrento Therapeutics
  • Client of Global Market Estimates - Solenis
  • Client of Global Market Estimates - Sartorius